Twareat Medical Care Company (9627) Fair Value & Analysis
Healthcare · SA · Market cap 372M SAR
Fair value as of: Aug 1, 2026
From 3 valuation models · updated today
Share price −6.9% over the past month.
What matters now
- The price sits above even our optimistic bull case (2.83 SAR). The favourable scenario is already priced in.
- Weak quality (32/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Price vs Fair Value (8 months)
8‑month range 7.40 SAR – 14.20 SAR · fair‑value band 1.83 SAR – 2.83 SAR · the 9.30 SAR price screens above the 2.36 SAR fair value. As of Aug 1, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Twareat Medical Care Company (9627) currently trades at 9.30 SAR, while our model-based Fair Value estimate is 2.36 SAR, implying the stock looks roughly 74.6% overvalued today. We read business quality at 32/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, Twareat Medical Care Company generated revenue of 183M SAR at a net margin of -5.6%. Revenue declined 7.2% year over year. It earns a return on equity of -18.1%. Net debt stands at 26.9M SAR. Fundamentals as of Aug 1, 2026
Our scenario range runs from 1.83 SAR (bear case) to 2.83 SAR (bull case); at 9.30 SAR, the current price sits above that range. The share trades about 35% below its 52-week high and 26% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside, at -75%, 9627 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 1, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Twareat Medical Care Company provides medical care services in remote and industrial areas in the Kingdom of Saudi Arabia. It offers home care; medical evacuation and transportation; medical support; occupational, industrial, and remote area clinics services.
Full company description
Twareat Medical Care Company provides medical care services in remote and industrial areas in the Kingdom of Saudi Arabia. It offers home care; medical evacuation and transportation; medical support; occupational, industrial, and remote area clinics services. The Group is engaged in general construction of residential buildings, renovation of residential and non-residential; buildings, stores of medical devices and products, hospitals, medical operations of hospitals, general medical; complexes, medical operations of medical complexes and one-day surgery centers, ambulance service centers, medical laboratories, home medical service centers, medical clinic mobile, telemedicine and telemedicine centers, medical operations of medical laboratories, radiology centers and supporting medical services, activities of drug stores, retail sale of medical devices, equipment and supplies, repair and maintenance of medical equipment and transformation of vehicles to medical equipment. Twareat Medical Care Company was founded in 2010 and is based in Al Khobar, the Kingdom of Saudi Arabia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Twareat Medical Care Company reported revenue of 183M SAR in FY2025 versus 150M SAR in FY2022, a compound +7.0%/yr. Reported net income was −10.3M SAR in FY2025.
Is 9627 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 1, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $162.06 | $282.55 | +74% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
| DaVita Inc DVAI34 | R$1,030 | R$1,096 | +7% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,489 | ₹2,128 | -75% |
| Fresenius Medical Care AG FMSC34 | R$112.00 | R$164.60 | +47% |
| Aier Eye Hospital Group 300015 | ¥8.25 | ¥6.73 | -18% |
Compare Twareat Medical Care Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Twareat Medical Care Company (9627) overvalued or undervalued?
What is the fair value of 9627?
What is the quality score of 9627?
What is the revenue of Twareat Medical Care Company (9627)?
What is the net profit margin of 9627?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Twareat Medical Care Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.